Novo Nordisk A/S Logo

Novo Nordisk A/S (NVO)

GPW

Currency in PLN
171.66
+3.32 (+1.97%)

Real-time Data

07:00 AM

Day's Range

171.66
171.66

52 wk Range

129.26
231.00

Analyst Ratings - NVO - Novo Nordisk A/S

Analyst ratings

DateFirmActionRating
Oct 27, 2025JefferiesAssumes coverageUnderperform
Sep 17, 2025BerenbergUpgradeHold → Buy
Aug 05, 2025UBSDowngradeBuy → Neutral
Jul 31, 2025HSBCDowngradeBuy → Hold
Jul 30, 2025BarclaysDowngradeOverweight → Equal-Weight
Jan 08, 2025UBSUpgradeSell → Buy
Jun 28, 2022UBSDowngradeNeutral → Sell
Jun 07, 2022JP MorganUpgradeNeutral → Overweight
May 31, 2022GuggenheimUpgradeNeutral → Buy
Mar 16, 2022Deutsche BankUpgradeHold → Buy
Items per row:

Estimates - NVO - Novo Nordisk A/S

Estimate momentum

Current quarter · How the consensus estimate has moved over the last 90 days.

Revised last month0/0

EPS estimates

PeriodAnalystsLowAverageHighYear ago
Current quarter-----
Next quarter-----
Current year-----
Next year-----

Earnings History - NVO - Novo Nordisk A/S

Estimate surprises

DateTimeEPS EstimateEPS ActualDifferenceSurprise PRC
2026-05-05-----
2026-02-04-----
2026-01-23-1.611.87+0.26‪+16.15%‬
2025-11-06-3.383.39+0.01‪+0.30%‬

The information on this page is provided for general informational purposes only and is not investment advice.

Market data provided by Twelve Data. Charting by TradingView.

Last updated:

Stocks news

Track Global Markets in Real Time with UA Finance

Download the app now and access live financial data, expert analysis, and trusted economic news to follow stocks, forex, gold, and cryptocurrencies with ease.